Several host proteins have been shown to play key roles in the life-cycle of vesicular stomatitis virus (VSV). We have identified an additional host protein, cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase activity, as one of the cellular factors required for VSV replication. Inhibition of the enzymatic activity of cellular CypA by cyclosporin A (CsA) or SDZ-211-811 resulted in a drastic inhibition of gene expression by VSV New Jersey (VSV-NJ) serotype, while these drugs had a significantly reduced effect on the genome expression of VSV Indiana (VSV-IND) serotype. Overexpression of a catalytically inactive mutant of CypA resulted in the reduction of VSV-NJ replication, suggesting a requirement for functional CypA for VSV-NJ infection. It was also shown that CypA interacted with the nucleocapsid (N) protein of VSV-NJ and VSV-IND in infected cells and was incorporated into the released virions of both serotypes. VSV-NJ utilized CypA for post-entry intracellular primary transcription, since inhibition of CypA with CsA reduced primary transcription of VSV-NJ by 85–90 %, whereas reduction for VSV-IND was only 10 %. Thus, it seems that cellular CypA binds to the N protein of both serotypes of VSV. However, it performs an obligatory function on the N protein activity of VSV-NJ, while its requirement is significantly less critical for VSV-IND N protein function. The different requirements for CypA by two serologically different viruses belonging to the same family has highlighted the utilization of specific host factors during their evolutionary lineages.
AlexanianA. R.,
BamburgJ. R.1999; Neuronal survival activity of s100 ββ is enhanced by calcineurin inhibitors and requires activation of NF- κ B. FASEB J 13:1611–1620
BanerjeeA. K.,
RhodesD. P.,
GillD. S.1984; Complete nucleotide sequence of the mRNA coding for the N protein of vesicular stomatitis virus (New Jersey serotype. Virology 137:432–438
BarikS.,
BanerjeeA. K.1992; Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A 89:6570–6574
BillichA.,
HammerschmidF.,
PeichlP.,
WengerR.,
ZenkeG.,
QuesniauxV.,
RosenwirthB.1995; Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein–cyclophilin A interactions. J Virol 69:2451–2461
BilselP. A.,
NicholS. T.1990; Polymerase errors accumulating during natural evolution of the glycoprotein gene of vesicular stomatitis virus Indiana serotype isolates. J Virol 64:4873–4883
BoseS.,
MalurA.,
BanerjeeA. K.2001; Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol 75:1984–1989
BraatenD.,
FrankeE. K.,
LubanJ.1996a; Cyclophilin is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol 70:3551–3560
BraatenD.,
FrankeE. K.,
LubanJ.1996b; Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIVCPZGAB but not group O HIV-1 or other primate immunodeficiency viruses. J Virol 70:4220–4227
ChoudharyS.,
DeB. P.,
BanerjeeA. K.2000; Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. J Virol 74:3634–3641
ChoudharyS.,
GaoJ.,
LeamanD. W.,
DeB. P.2001; Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription. J Virol 75:4823–4831
ColganJ.,
YuanH. H.,
FrankeE. K.,
LubanJ.1996; Binding of the human immunodeficiency virus type 1 gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires gag dimerization. J Virol 70:4299–4310
DasT.,
GuptaA. K.,
SimsP. W.,
GelfandC. A.,
JentoftJ. E.,
BanerjeeA. K.1995; Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA polymerase of vesicular stomatitis virus. J Biol Chem 270:24100–24107
DasT.,
MathurM.,
GuptaA. K.,
JanssenG. M.,
BanerjeeA. K.1998; RNA polymerase of vesicular stomatitis virus specifically associates with translational elongation factor-1 αβγ for its activity. Proc Natl Acad Sci U S A 95:1449–1454
DeB. P.,
ThorntonG. B.,
LukD.,
BanerjeeA. K.1982; Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc Natl Acad Sci U S A 79:7137–7141
DeB. P.,
LesoonA.,
BanerjeeA. K.1991; Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis. J Virol 65:3268–3275
DeB. P.,
HoffmanM. A.,
ChoudharyS.,
HuntleyC. C.,
BanerjeeA. K.2000; Role of NH2 and COOH terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication. J Virol 74:5886–5895
DietrichL.,
EhrlichL. S.,
LaGrassaT. J.,
Ebbets-ReedD.,
CarterC.2001; Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. J Virol 75:4721–4733
GuptaA. K.,
BanerjeeA. K.1997; Expression and purification of N–P complex from Escherichia coli : role in genome RNA transcription and replication in vitro. J Virol 71:4264–4271
GuptaA. K.,
DrazbaJ. A.,
BanerjeeA. K.1998; Specific interaction of heterogenous nuclear ribonucleoprotein particle U with the leader RNA sequence of vesicular stomatitis virus. J Virol 72:8532–8540
GurerC.,
CimarelliA.,
LubanJ.2002; Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol 76:4666–4670
HartyR. N.,
ParagasJ.,
SudolM.,
PaleseP.1999; A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 73:2921–2929
HartyR. N.,
BrownM. E.,
McGettiganJ. P.,
WangG.,
JayakarH. R.,
HuibregtseJ. M.,
WhittM. A.,
SchnellM. J.2001; Rhabdoviruses and the cellular ubiquitin–proteasome system: a budding interaction. J Virol 75:10623–10629
HeggenessM. H.,
ScheidA.,
ChoppinP. W.1980; Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A 77:2631–2635
HelekarS. A.,
PatrickJ.1997; Peptidyl-prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression. Proc Natl Acad Sci U S A 94:5432–5437
HuJ.,
ToftD.,
SeegerC.1997; Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J 16:59–68
KopeckyS. A.,
WillinghamM. C.,
LylesD. S.2001; Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol 75:12169–12181
LodishH. F.,
KongN.1991; Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. J Biol Chem 266:14835–14838
LubanJ.,
BossoltK. L.,
FrankeE. K.,
KalpanaG. V.,
GoffS. P.1993; Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B. Cell 73:1067–1078
MoyerS. A.,
BakerS. C.,
LessardJ. L.1986; Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A 83:5405–5409
NauwynckH. J.,
DuanX.,
FavoreelH. W.,
VanOostveldtP.,
PensaertM. B.1999; Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor mediated endocytosis. J Gen Virol 80:297–305
OnoK.,
Dubois-DalcqM. E.,
SchubertM.,
LazzariniR. A.1987; A mutated membrane protein of vesicular stomatitis virus has an abnormal distribution within the infected cell and causes defective budding. J Virol 61:1332–1341
PelusoR. W.,
MoyerS. A.1983; Initiation and replication of vesicular stomatitis virus genome RNA in a cell free system. Proc Natl Acad Sci U S A 80:3198–3202
RoseJ. K.,
WhittM. A.2001; Rhabdoviridae : the viruses and their replication. In Fields Virology , 4th edn. pp 1221–1244 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
SchneuwlyS.,
ShortridgeR. D.,
LarriveeD. C.,
OnoT.,
OzakiM.,
PakW. L.1989; Drosophilia ninaA gene encodes an eye specific cyclophilin. Proc Natl Acad Sci U S A 86:5390–5394
SteinmannB.,
BrucknerP.,
Superti-FurgaA.1991; Cyclosporin A slows collagen triple helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans isomerase. J Biol Chem 266:1299–1303
StreblowD. N.,
KitabwallaM.,
MalkovskyM.,
PauzaC. D.1998; Cyclophilin A modulates processing of human immunodeficiency virus type 1 p55 gag: mechanism for antiviral effects of cyclosporin A. Virology 245:197–202
TaigenT.,
DeWindtL. J.,
LimH. W.,
MolkentinJ. D.2000; Targeted inhibition of calcineurin prevents agonist induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 97:1196–1201
ThaliM.,
BukovskyA.,
KondoE.,
RosenwirthB.,
WalshC. T.,
SodroskiJ.,
GottlingerH. G.1994; Functional association of cyclophilin A with HIV-1 virions. Nature 372:363–365
ZhouA.,
ParanjapeM. J. M.,
HasselB. A.,
NieH.,
ShahS.,
GalinskiB.,
SilvermanR. H.1998; Impact of Rnase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 18:953–961
ZydowskyL. D.,
EtzkornF. A.,
ChangH. Y.,
FergusonS. B.,
StolzL. A.,
HoS. I.,
WalshC. T.1992; Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1:1092–1099